close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Veracyte, Inc.

< Previous 1 2 3 4 5 6 7 Next >
News headline image
Veracyte Announces Three Abstracts to Be Presented at AACR Annual Meeting 2023 Highlighting the Company’s Multi-Omics Capabilities and Tools for Biopharma Partners
From Veracyte, Inc.
Via Business Wire
Tickers VCYT
News headline image
Veracyte Provides Statement on Impact of Events Surrounding Silicon Valley Bank
From Veracyte, Inc.
Via Business Wire
Tickers VCYT
News headline image
Veracyte to Participate in Upcoming Investor Conferences
From Veracyte, Inc.
Via Business Wire
Tickers VCYT
News headline image
Veracyte Announces Fourth Quarter and Full-Year 2022 Financial Results
From Veracyte, Inc.
Via Business Wire
Tickers VCYT
News headline image
Data Published in “The Red Journal” Validate Prognostic Value of Veracyte’s Decipher Prostate Genomic Classifier for Men with High-Risk Prostate Cancer
From Veracyte, Inc.
Via Business Wire
Tickers VCYT
News headline image
New Data To Be Presented at 2023 ASCO GU Suggest Decipher GRID-Derived Gene Expression Signature Can Help Personalize Prostate Cancer Treatment
From Veracyte, Inc.
Via Business Wire
Tickers VCYT
News headline image
Veracyte to Release Fourth Quarter and Full-Year 2022 Financial Results on February 22, 2023
From Veracyte, Inc.
Via Business Wire
Tickers VCYT
News headline image
Veracyte Announces Multiple Decipher Urologic Testing Abstracts to be Presented at the 2023 ASCO Genitourinary (GU) Cancers Symposium
From Veracyte, Inc.
Via Business Wire
Tickers VCYT
News headline image
Veracyte Announces New Data Suggesting Afirma Testing Can Help Personalize Care for Patients with Thyroid Nodules
From Veracyte, Inc.
Via Business Wire
Tickers VCYT
News headline image
Data Published in JCEM Demonstrate Strong Real-World Performance of Veracyte’s Afirma GSC in Thyroid Cancer Diagnosis
From Veracyte, Inc.
Via Business Wire
Tickers VCYT
News headline image
Veracyte Announces Third Quarter 2022 Financial Results
From Veracyte, Inc.
Via Business Wire
Tickers VCYT
News headline image
Veracyte Announces Three Abstracts to Be Presented at SITC 2022 Annual Meeting
From Veracyte, Inc.
Via Business Wire
Tickers VCYT
News headline image
Veracyte to Participate in the Credit Suisse 31st Annual Healthcare Conference
From Veracyte, Inc.
Via Business Wire
Tickers VCYT
News headline image
New Data Suggest Decipher GRID-Derived Genomic Signature Can Help Identify Men with Prostate Cancer Who Should Receive High-Dose Radiotherapy
From Veracyte, Inc.
Via Business Wire
Tickers VCYT
News headline image
Veracyte Data Presented at ATA Annual Meeting Provide New Insights into Molecular Underpinnings of Thyroid Cancer
From Veracyte, Inc.
Via Business Wire
Tickers VCYT
News headline image
New Data Presented at CHEST 2022 Reinforce Clinical Value of Veracyte’s Genomic Tests in Interstitial Lung Disease and Lung Cancer
From Veracyte, Inc.
Via Business Wire
Tickers VCYT
News headline image
Veracyte to Release Third Quarter 2022 Financial Results on November 2, 2022
From Veracyte, Inc.
Via Business Wire
Tickers VCYT
News headline image
New Data Published in JNCI Demonstrate Veracyte’s Decipher Prostate Genomic Classifier May Improve Identification of Aggressive Prostate Cancer in African American Men
From Veracyte, Inc.
Via Business Wire
Tickers VCYT
News headline image
Veracyte Names John Leite, Ph.D., as General Manager of Pulmonology & Market Access
From Veracyte, Inc.
Via Business Wire
Tickers VCYT
News headline image
New Data Presented at ESMO 2022 Show Veracyte’s Decipher Prostate Genomic Classifier May Help Inform Personalized Treatment Decisions in Men with Advanced Prostate Cancer
From Veracyte, Inc.
Via Business Wire
Tickers VCYT
News headline image
New Data Suggest Veracyte’s Envisia Genomic Classifier Can Help Predict Disease Progression in Interstitial Lung Disease Patients Treated with Combination Immunosuppressive Therapy
From Veracyte, Inc.
Via Business Wire
Tickers VCYT
News headline image
Veracyte to Participate in the Morgan Stanley 20th Annual Global Healthcare Conference
From Veracyte, Inc.
Via Business Wire
Tickers VCYT
News headline image
Veracyte Announces Seven Abstracts to Be Presented at ESMO Congress 2022
From Veracyte, Inc.
Via Business Wire
Tickers VCYT
News headline image
New Data in Nature Medicine Suggest Pre-Treatment Tumor Microenvironment Can Impact Response for CAR T-Cell Therapy in Patients with Large B-Cell Lymphoma
From Veracyte, Inc.
Via Business Wire
Tickers VCYT
News headline image
Veracyte Appoints Eliav Barr, M.D., to Its Board of Directors
From Veracyte, Inc.
Via Business Wire
Tickers VCYT
News headline image
Veracyte Announces Second Quarter 2022 Financial Results
From Veracyte, Inc.
Via Business Wire
Tickers VCYT
News headline image
Veracyte Announces New Clinical Validation Data for RNA Sequencing-Based Afirma Medullary Thyroid Cancer Classifier Published in Thyroid
From Veracyte, Inc.
Via Business Wire
Tickers VCYT
News headline image
Veracyte to Release Second Quarter 2022 Financial Results on August 2, 2022
From Veracyte, Inc.
Via Business Wire
Tickers VCYT
News headline image
New Data Published in PLOS ONE Validate the Clinical Performance of Veracyte’s Percepta Genomic Sequencing Classifier in Lung Cancer Diagnosis
From Veracyte, Inc.
Via Business Wire
Tickers VCYT
News headline image
Veracyte Named a San Francisco “Bay Area Top Workplace” For Ninth Consecutive Year
From Veracyte, Inc.
Via Business Wire
Tickers VCYT
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at /week.